Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis

IMPORTANCE: Therapeutic options for patients with secondary progressive multiple sclerosis (SPMS) are limited. OBJECTIVE: To analyze disability progression in patients with SPMS treated with rituximab compared with matched control patients never treated with rituximab. DESIGN, SETTING, AND PARTICIPA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA Neurol
Asıl Yazarlar: Naegelin, Yvonne, Naegelin, Peter, von Felten, Stefanie, Lorscheider, Johannes, Sonder, Judith, Uitdehaag, Bernard M. J., Scotti, Barbara, Zecca, Chiara, Gobbi, Claudio, Kappos, Ludwig, Derfuss, Tobias
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2019
Konular:
Original Investigation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439730/
https://ncbi.nlm.nih.gov/pubmed/30615019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.4239
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller